Biotech News

Amarin to Report Third Quarter 2026 Financial Results and Host Conference Call on October 28, 2026

Amarin Corporation (AMRN)Amarin CorporationEarnings

Amarin Corporation plc (NASDAQ: AMRN), a company advancing the science of cardiovascular therapeutics worldwide, today announced that it will report third quarter 2026 financial results and conduct a conference call on Wednesday, October 28, 2026. The Company will issue a press release detailing its third quarter 2026 financial results in the pre-market hours, followed by a conference call with senior management at 8:00 a.m. ET.

Related news

Amarin Corporation

Cardiovascular Therapeutics Company Amarin is a cardiovascular-focused pharmaceutical company built around prescription icosapent ethyl. Its commercial strategy combines a continuing U.S. presence with regional partners responsible for regulatory, market-access, and sales activities internationally. VASCEPA and VAZKEPA The product is...

Recent company news

Stock data

Close
11.26 USD
Market cap
303.42M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States